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l14th International Congress on Infectious Diseases (ICID) Abs
the main food and drinks related infections like hepatitis
A and typhoid fever, as well as the life threatening disease
rabies. Protection against hepatitis B is high through vacci-
nation and should be considered in long term and frequent
travelers. Our experience in Travel Vaccines will be showed.
doi:10.1016/j.ijid.2010.02.1490
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Routine Immunization
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Routine immunization has become among the most com-
mon preventive tools use by medical practitioners all over
the World. Vaccinations have proven to eradicated and con-
trol many preventable diseases such as smallpox, polio,
measles, tetanus and diphtheria among others. Globally,
children vaccines calendars are most familiar for all devel-
oped and underdeveloped countries. However, only until
recently that adolescents and adult vaccinations are known
for many underdeveloped countries. Travel medicine is a
good way to promote immunization calendars for all and
should be a goal for our performance because there is an
intrinsic synergistic relationship between them. The World
Health Organization (WHO) has an important role in rec-
ommending routine immunizations for all groups of ages
(children, adolescents and adults), diverse regions, and cer-
tain risk populations. WHO initial main program was the
Expanded Program in Immunization which included vaccines
for the maternal and children population under one year
of age. Now among other goals are integrating immuniza-
tions’ in the health systems and immunizing within a global
health interdependence context are global objectives. Most
countries follow the basic program for children and must
comply with mandatory travel vaccines by the new Inter-
national Health Regulations (2005). However, still the risk
of lifethreatening illness is very high especially in under-
developed regions because still the vaccines coverage is
low, therefore; the risk for reemerging diseases and spread-
ing consequently with illnesses, disability and deaths. Also,
there are new technologies and vaccines available which
make difﬁcult to ﬁnancially provide the service for all. New
biological products developments and technologies, vac-
cines primary series, interval of doses, and boosters must
be learned by travel medicine practitioners. Also, adverse
reactions and contraindications, particularly for those trav-
elers with special needs or conditions in order to provide
good advice during their pre-travel consultation.
doi:10.1016/j.ijid.2010.02.1491
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accines Recommended for Global Travelers
.S. Chaves
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Individuals travel for many reasons, including holidays,
ecreation, business, visiting friends and relatives, health
reatments, educational experiences or others purposes.
he World Tourism Organization predicts that international
ourist travel may top 1 billion by 2010. Given the growth of
nternational travel, the area travel medicine has expanded
f the worldwide. The vaccination is one of the steps that
ealth providers for giving travelers, and the vaccines rec-
mmended prior to international travel can be divided into
hree fases: those that are routine, those that may be
equired and those that are recommended on the basis an
ndividual risk assessment for the traveler. Considerations in
hoosing vaccines include destination; season and duration
f travel; activities planned; severity of disease; whether
he trip will be urban, rural, or remote from medical care;
ime remaining before departure; vaccine availability, cost,
nd the number of doses needed; history of allergy to
accines or their components; medications currently being
aken; pregnancy; chronic illness; and underlying medical
onditions such as a compromised immune system. Vac-
ines recommended for travelers and that will be discussed:
holera, hepatitis A, Typhoid fever, Japanese encephalitis,
eningococcal disease, rabies and Tick-borne encephali-
is. Conclusion: Vaccination is a highly effective method
f preventing certain infectious diseases. Travel medicine
ractitioners must be care when to evaluate immunization
tatus of the traveler with goal to consider or not to vaccine
or patient. Travelers should be informed about the risks of
ontracting disease, as well as, the risks of adverse events
rom immunizations.
oi:10.1016/j.ijid.2010.02.1492
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The purpose of this talk is to brieﬂy address some high-
ights about the illness and its burden in relation to travel,
ew epidemiological aspects, particularly focusing on the
aribbean and South American situation in 2008-9. Concep-
ual points regarding yellow fever vaccine will be reviewed,
ocusing specially on severe adverse events described in the
ast 10 years, which have put the actual vaccine risk/beneﬁt
elation under close scrutiny. Some practical situations
egarding its indication that could lead to controversy will
e also discussed.
oi:10.1016/j.ijid.2010.02.1493
